| Year |
Citation |
Score |
| 2019 |
Guo S, Hossain A, Zhang C, Mottamal M, Liu J, Wiese T, Wang G. SAT-341 Pharmacology and Metabolism of GLL398 an Oral Selective Estrogen Receptor Degrader for Endocrine Therapy of Breast Cancer Journal of the Endocrine Society. 3. DOI: 10.1210/Js.2019-Sat-341 |
0.408 |
|
| 2019 |
Crease K, Williams C, ma P, Skripnikova E, Wiese T. MON-034 Novel Estrogen Activity and Gene Regulation Induced by Personal Care Products in Breast Cancer Cells Journal of the Endocrine Society. 3. DOI: 10.1210/Js.2019-Mon-034 |
0.392 |
|
| 2019 |
Baer C, Ragland E, Ma P, Wiese T. MON-033 Evaluating the Estrogen Activity of OTC Products Containing Parabens Journal of the Endocrine Society. 3. DOI: 10.1210/Js.2019-Mon-033 |
0.32 |
|
| 2018 |
Guo S, Zhang C, Bratton M, Mottamal M, Liu J, Ma P, Zheng S, Zhong Q, Yang L, Wiese TE, Wu Y, Ellis MJ, Matossian M, Burow ME, Miele L, et al. ZB716, a steroidal selective estrogen receptor degrader (SERD), is orally efficacious in blocking tumor growth in mouse xenograft models. Oncotarget. 9: 6924-6937. PMID 29467940 DOI: 10.18632/Oncotarget.24023 |
0.428 |
|
| 2017 |
Powell D, Chandra S, Dodson K, Shaheen F, Wilt K, Ireland S, Syed M, Dash S, Wiese T, Mandal T, Kundu A. Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 28131717 DOI: 10.1016/J.Ejpb.2017.01.011 |
0.356 |
|
| 2017 |
Liu J, Zheng S, Guo S, Zhang C, Zhong Q, Zhang Q, Ma P, Skripnikova EV, Bratton MR, Wiese TE, Wang G. Rational Design of a Boron-Modified Triphenylethylene (GLL398) as an Oral Selective Estrogen Receptor Downregulator. Acs Medicinal Chemistry Letters. 8: 102-106. PMID 28105283 DOI: 10.1021/Acsmedchemlett.6B00410 |
0.411 |
|
| 2016 |
Liu J, Zheng S, Akerstrom VL, Yuan C, Ma Y, Zhong Q, Zhang C, Zhang Q, Guo S, Ma P, Skripnikova EV, Bratton MR, Pannuti A, Miele L, Wiese TE, et al. Fulvestrant-3 Boronic Acid (ZB716): An Orally Bioavailable Selective Estrogen Receptor Downregulator (SERD). Journal of Medicinal Chemistry. PMID 27529700 DOI: 10.1021/Acs.Jmedchem.6B00753 |
0.399 |
|
| 2015 |
Bratton MR, Martin EC, Elliott S, Rhodes LV, Collins-Burow BM, McLachlan JA, Wiese TE, Boue SM, Burow ME. Glyceollin, a novel regulator of mTOR/p70S6 in estrogen receptor positive breast cancer. The Journal of Steroid Biochemistry and Molecular Biology. 150: 17-23. PMID 25771071 DOI: 10.1016/J.Jsbmb.2014.12.014 |
0.472 |
|
| 2014 |
Sun Y, Miller CA, Wiese TE, Blake DA. Methylated phenanthrenes are more potent than phenanthrene in a bioassay of human aryl hydrocarbon receptor (AhR) signaling. Environmental Toxicology and Chemistry / Setac. 33: 2363-7. PMID 25043914 DOI: 10.1002/Etc.2687 |
0.304 |
|
| 2013 |
Cao B, Liu X, Li J, Liu S, Qi Y, Xiong Z, Zhang A, Wiese T, Fu X, Gu J, Rennie PS, Sartor O, Lee BR, Ip C, Zhao L, et al. 20(S)-protopanaxadiol-aglycone downregulation of the full-length and splice variants of androgen receptor. International Journal of Cancer. Journal International Du Cancer. 132: 1277-87. PMID 22907191 DOI: 10.1002/Ijc.27754 |
0.326 |
|
| 2012 |
Bratton MR, Frigo DE, Segar HC, Nephew KP, McLachlan JA, Wiese TE, Burow ME. The organochlorine o,p'-DDT plays a role in coactivator-mediated MAPK crosstalk in MCF-7 breast cancer cells. Environmental Health Perspectives. 120: 1291-6. PMID 22609851 DOI: 10.1289/Ehp.1104296 |
0.377 |
|
| 2012 |
Tilghman SL, Bratton MR, Segar HC, Martin EC, Rhodes LV, Li M, McLachlan JA, Wiese TE, Nephew KP, Burow ME. Endocrine disruptor regulation of microRNA expression in breast carcinoma cells. Plos One. 7: e32754. PMID 22403704 DOI: 10.1371/Journal.Pone.0032754 |
0.423 |
|
| 2012 |
Schenck K, Rosenblum L, Wiese TE, Wymer L, Dugan N, Williams D, Mash H, Merriman B, Speth T. Removal of estrogens and estrogenicity through drinking water treatment. Journal of Water and Health. 10: 43-55. PMID 22361701 DOI: 10.2166/Wh.2011.135 |
0.344 |
|
| 2011 |
Khupse RS, Sarver JG, Trendel JA, Bearss NR, Reese MD, Wiese TE, Boue SM, Burow ME, Cleveland TE, Bhatnagar D, Erhardt PW. Biomimetic syntheses and antiproliferative activities of racemic, natural (-), and unnnatural (+) glyceollin I. Journal of Medicinal Chemistry. 54: 3506-23. PMID 21513275 DOI: 10.1021/Jm101619E |
0.459 |
|
| 2011 |
Antoon JW, Meacham WD, Bratton MR, Slaughter EM, Rhodes LV, Ashe HB, Wiese TE, Burow ME, Beckman BS. Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer Journal of Molecular Endocrinology. 46: 205-216. PMID 21321095 DOI: 10.1530/Jme-10-0116 |
0.467 |
|
| 2011 |
Boué SM, Burow ME, Wiese TE, Shih BY, Elliott S, Carter-Wientjes CH, McLachlan JA, Bhatnagar D. Estrogenic and antiestrogenic activities of phytoalexins from red kidney bean (Phaseolus vulgaris L.). Journal of Agricultural and Food Chemistry. 59: 112-20. PMID 21133423 DOI: 10.1021/Jf102255U |
0.44 |
|
| 2011 |
Cao B, Liu X, Li J, Xiong Z, Wiese T, Cheng H, Rennie PS, Zhao L, Zhang H, Dong Y. Abstract 5561: 20(S)-Protopanaxadiol-aglycone downregulates full-length and ligand-independent splice variants of androgen receptor Cancer Research. 71: 5561-5561. DOI: 10.1158/1538-7445.Am2011-5561 |
0.356 |
|
| 2010 |
Antoon JW, White MD, Meacham WD, Slaughter EM, Muir SE, Elliott S, Rhodes LV, Ashe HB, Wiese TE, Smith CD, Burow ME, Beckman BS. Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640. Endocrinology. 151: 5124-35. PMID 20861237 DOI: 10.1210/En.2010-0420 |
0.469 |
|
| 2010 |
Jiang Q, Payton-Stewart F, Elliott S, Driver J, Rhodes LV, Zhang Q, Zheng S, Bhatnagar D, Boue SM, Collins-Burow BM, Sridhar J, Stevens C, McLachlan JA, Wiese TE, Burow ME, et al. Effects of 7-O substitutions on estrogenic and anti-estrogenic activities of daidzein analogues in MCF-7 breast cancer cells. Journal of Medicinal Chemistry. 53: 6153-63. PMID 20669983 DOI: 10.1021/Jm100610W |
0.491 |
|
| 2010 |
Payton-Stewart F, Khupse RS, Boué SM, Elliott S, Zimmermann MC, Skripnikova EV, Ashe H, Tilghman SL, Beckman BS, Cleveland TE, McLachlan JA, Bhatnagar D, Wiese TE, Erhardt P, Burow ME. Glyceollin I enantiomers distinctly regulate ER-mediated gene expression. Steroids. 75: 870-8. PMID 20493896 DOI: 10.1016/J.Steroids.2010.05.007 |
0.458 |
|
| 2010 |
Zimmermann MC, Tilghman SL, Boué SM, Salvo VA, Elliott S, Williams KY, Skripnikova EV, Ashe H, Payton-Stewart F, Vanhoy-Rhodes L, Fonseca JP, Corbitt C, Collins-Burow BM, Howell MH, Lacey M, ... ... Wiese TE, et al. Glyceollin I, a novel antiestrogenic phytoalexin isolated from activated soy. The Journal of Pharmacology and Experimental Therapeutics. 332: 35-45. PMID 19797619 DOI: 10.1124/Jpet.109.160382 |
0.447 |
|
| 2009 |
Boué SM, Tilghman SL, Elliott S, Zimmerman MC, Williams KY, Payton-Stewart F, Miraflor AP, Howell MH, Shih BY, Carter-Wientjes CH, Segar C, Beckman BS, Wiese TE, Cleveland TE, McLachlan JA, et al. Identification of the potent phytoestrogen glycinol in elicited soybean (Glycine max). Endocrinology. 150: 2446-53. PMID 19116342 DOI: 10.1210/En.2008-1235 |
0.477 |
|
| 2008 |
Zhou C, Nitschke AM, Xiong W, Zhang Q, Tang Y, Bloch M, Elliott S, Zhu Y, Bazzone L, Yu D, Weldon CB, Schiff R, McLachlan JA, Beckman BS, Wiese TE, et al. Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype. Breast Cancer Research : Bcr. 10: R105. PMID 19087274 DOI: 10.1186/Bcr2210 |
0.33 |
|
| 2003 |
Boué SM, Wiese TE, Nehls S, Burow ME, Elliott S, Carter-Wientjes CH, Shih BY, McLachlan JA, Cleveland TE. Evaluation of the estrogenic effects of legume extracts containing phytoestrogens. Journal of Agricultural and Food Chemistry. 51: 2193-9. PMID 12670155 DOI: 10.1021/Jf021114S |
0.387 |
|
| 2003 |
Coleman KP, Toscano WA, Wiese TE. QSAR Models of the in vitro Estrogen Activity of Bisphenol A Analogs Qsar & Combinatorial Science. 22: 78-88. DOI: 10.1002/Qsar.200390008 |
0.428 |
|
| 2002 |
Rubin VN, Ruenitz PC, Boyd JL, Boudinot FD, Wiese TE. Characterization of selective estrogen receptor modulator (SERM) activity in two triarylethylene oxybutyric acids. Biochemical Pharmacology. 63: 1517-25. PMID 11996894 DOI: 10.1016/S0006-2952(02)00893-6 |
0.416 |
|
| 2001 |
Burow ME, Boue SM, Collins-Burow BM, Melnik LI, Duong BN, Carter-Wientjes CH, Li S, Wiese TE, Cleveland TE, McLachlan JA. Phytochemical glyceollins, isolated from soy, mediate antihormonal effects through estrogen receptor alpha and beta. The Journal of Clinical Endocrinology and Metabolism. 86: 1750-8. PMID 11297613 DOI: 10.1210/Jcem.86.4.7430 |
0.4 |
|
| 1998 |
Bolger R, Wiese TE, Ervin K, Nestich S, Checovich W. Rapid screening of environmental chemicals for estrogen receptor binding capacity. Environmental Health Perspectives. 106: 551-557. PMID 9721254 DOI: 10.1289/Ehp.98106551 |
0.39 |
|
| 1997 |
Wiese TE, Polin LA, Palomino E, Brooks SC. Induction of the estrogen specific mitogenic response of MCF-7 cells by selected analogues of estradiol-17β: A 3D QSAR study Journal of Medicinal Chemistry. 40: 3659-3669. PMID 9357533 DOI: 10.1021/Jm9703294 |
0.446 |
|
| 1997 |
Earl Gray L, Kelce WR, Wiese T, Tyl R, Gaido K, Cook J, Klinefelter G, Desaulniers D, Wilson E, Zacharewski T, Waller C, Foster P, Laskey J, Reel J, Giesy J, et al. Endocrine Screening Methods Workshop report: Detection of estrogenic and androgenic hormonal and antihormonal activity for chemicals that act via receptor or steroidogenic enzyme mechanisms Reproductive Toxicology. 11: 719-750. PMID 9311581 DOI: 10.1016/S0890-6238(97)00025-7 |
0.361 |
|
| 1995 |
Wiese TE, Dukes D, Brooks SC. A molecular modeling analysis of diethylstilbestrol conformations and their similarity to estradiol-17β Steroids. 60: 802-808. PMID 8650702 DOI: 10.1016/0039-128X(95)00143-E |
0.33 |
|
| 1994 |
Wiese TE, Brooks SC. Molecular modeling of steroidal estrogens : novel conformations and their role in biological activity The Journal of Steroid Biochemistry and Molecular Biology. 50: 61-73. PMID 8049135 DOI: 10.1016/0960-0760(94)90173-2 |
0.339 |
|
| 1993 |
VanderKuur JA, Wiese T, Brooks SC. Influence of estrogen structure on nuclear binding and progesterone receptor induction by the receptor complex. Biochemistry. 32: 7002-8. PMID 8334129 DOI: 10.1021/Bi00078A027 |
0.4 |
|
| 1993 |
Horwitz JP, Massova I, Wiese TE, Wozniak AJ, Corbett TH, Sebolt-Leopold JS, Capps DB, Leopold WR. Comparative molecular field analysis of in vitro growth inhibition of L1210 and HCT-8 cells by some pyrazoloacridines. Journal of Medicinal Chemistry. 36: 3511-6. PMID 8280289 DOI: 10.1021/Jm00075A004 |
0.315 |
|
| 1992 |
Wiese TE, Kral LG, Dennis KE, Butler WB, Brooks SC. Optimization of estrogen growth response in MCF-7 cells. In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association. 28: 595-602. PMID 1429362 DOI: 10.1007/Bf02631033 |
0.325 |
|
| Show low-probability matches. |